Skip to main content
Equibles

Walleye Trading LLC

Position in RNA — Atrium Therapeutics, Inc.

CIK 1388391 NEW YORK, NY
Back to RNA Full portfolio

Position in RNA

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$53,504
+$4,998 QoQ
Shares Held
3,978
+9.6% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#98
of 154 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNA Over Time

Shares Held

Position Value (USD)

Derivatives in RNA

reported options exposure · as of Jun 30, 2026
CallValue
$67,250
CallShares
5,000
PutValue
$281,105
PutShares
20,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Walleye Trading LLC holds $28,211,005 across 28 Biotechnology names. RNA ranks #25 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 11,407 $7,112,720
2 MRNA
Moderna, Inc.
 101,066 $7,077,651
3 BNTX
BioNTech SE
 25,690 $2,390,454
4 ALNY
Alnylam Pharmaceuticals, Inc.
 6,037 $1,817,318
5 VKTX
Viking Therapeutics, Inc.
 33,938 $1,323,921
6 TGTX
Tg Therapeutics, Inc.
 19,679 $1,081,164
7 CRSP
CRISPR Therapeutics AG
 18,595 $1,014,171
8 ABVX
Abivax S.A.
 6,790 $904,835

All Filings in RNA

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $67,250 5,000
2026-06-30 $281,105 20,900
2026-06-30 $53,504 3,978
2026-03-31 $288,792 21,600
2026-03-31 $48,506 3,628
2026-03-31 $69,524 5,200